Status:
COMPLETED
Digital Tool Enhancing GPs' Information Management for Patients with Multimorbidity - a Pilot Study
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Asthma
Breast Neoplasms
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The gp-multitool.de study is a cluster-randomized controlled trial that aims to enhance evidence-based and patient-centered care for patients with multimorbidity by assessing and providing information...
Detailed Description
The gp-multitool.de study is a cluster-randomized controlled trial that enhances evidence-based and patient-centered care for patients with multimorbidity by assessing and providing information releva...
Eligibility Criteria
Inclusion
- participation in a DMP; in Germany, DMPs have been implemented in outpatient care for asthma, breast neoplasms, coronary heart disease, diabetes mellitus type 1, diabetes mellitus type 2, and chronic obstructive pulmonary disease
- at least two of the following coexisting conditions: Hypertension, Lipid metabolism disorders, Chronic low back pain, Severe vision reduction, Joint arthrosis, Diabetes mellitus, Chronic ischemic heart disease, Thyroid dysfunction, Cardiac arrhythmias, Obesity, Hyperuricemia/Gout, Prostatic hyperplasia, Lower limb varicosis, Liver diseases, Depression, Asthma/COPD, Gynaecological problems, Atherosclerosis/PAOD, Osteoporosis, Renal insufficiency, Cerebral ischemia/Chronic stroke, Cardiac insufficiency, Severe hearing loss, Chronic cholecystitis/Gallstones, Somatoform disorders, Hemorrhoids, Intestinal diverticulosis, Rheumatoid arthritis/Chronic polyarthritis, Cardiac valve disorders, Neuropathies, Dizziness, Dementias, Urinary incontinence, Urinary tract calculi, Anemias, Anxiety, Psoriasis, Migraine/chronic headache, Parkinson's disease, Cancers, Allergies, Chronic gastritis/GERD, Sexual dysfunction, Insomnia, Tobacco abuse, Hypotension
Exclusion
- no capacity to consent
- functional limitations precluding participation in the intervention (eg, loss of vision)
- functional limitations precluding participation in telephone interviews (eg, loss of hearing)
- limited German language skills precluding participation in telephone interviews
- no access to a personal device with access to the internet (i.e., smartphone, tablet or personal computer)
- participation in other trials during the observation time of the pilot study
Key Trial Info
Start Date :
October 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2024
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT06061172
Start Date
October 2 2023
End Date
August 29 2024
Last Update
December 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany, 20246